A study of the ameliorating effects of carnitine on hepatic steatosis induced by total parenteral nutrition in rats

Table 1 The initial body weight (BW) of rats in different groups (mean ± SD)

	Normal group			Cirrhotic group
	A1	B1	C1	A2	B2	C2
n	6	6	6	6	6	6
BW (g)	263.8 ± 13.5	268.1 ± 11.8	270.8 ± 10.1	318.2 ± 7.1	318.7 ± 5.3	321.8 ± 6.9

Table 2 Liver function in various groups (mean ± SD)

	Normal group			Cirrhotic group
	A1	B1	C1	A2	B2	C2
TBIL (μmol/L)	12.4 ± 3.2	13.8 ± 4.8	2.0 ± 5.1	13.0 ± 2.7	13.2 ± 2.1	12.0 ± 2.5
AST (I U/L)	156.9 ± 28.6	187.2 ± 29.6	179.7 ± 22.3	264.0 ± 23.6	269.5 ± 26.7	269.5 ± 102.0
ALT (I U/L)	54.0 ± 11.0	43.8 ± 11.7	44.8 ± 15.1	106.0 ± 24.0	117.7 ± 25.0	89.2 ± 22.7
ALB (g/L)	38.8 ± 1.7	37.8 ± 1.0	39.5 ± 3.1	32.2 ± 2.8	5.8 ± 1.9 a	27.2 ± 2.4 a

^aP < 0.05, vs group A2.

Table 3 Hepatic fat content in various groups (mean ± SD)

Group	Normal group			Cirrhotic group
	A1	B1	C1	A2	B2	v
TG (μmol/g)	5.15 ± 0.76	39.33 ± 2.42a	17.00 ± 3.95ae	9.05 ± 0.78	26.58 ± 2.76c	13.11 ± 8.42cg
CHO (μmol/g)	5.59 ± 0.66	13.13 ± 1.06a	8.98 ± 1.50ae	6.30 ± 0.65	10.2 ± 0.83c	7.98 ± 0.99cg

^aP < 0.05, vs group A1;

^cP < 0.05, vs group A2;

^eP < 0.05, vs group B1;

^gP < 0.05, vs group B2.